4//SEC Filing
Schwarzer Fred 4
Accession 0001209191-22-062258
CIK 0001496323other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 8:08 PM ET
Size
8.2 KB
Accession
0001209191-22-062258
Insider Transaction Report
Form 4
Schwarzer Fred
DirectorCEO and President
Transactions
- Sale
Common Stock
2022-12-16$18.77/sh−7,955$149,352→ 24,774 total - Sale
Common Stock
2022-12-16$19.36/sh−4,414$85,453→ 20,360 total
Holdings
- 196,718(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $18.29 to $19.289. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $19.30 to $19.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]The shares are held by Fred M. Schwarzer & Deborah R. Schwarzer TTEES of the Schwarzer Family Trust U/A DTD 04/05/2018.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001787361
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 8:08 PM ET
- Size
- 8.2 KB